SUBSCRIBE
SUBSCRIBE
News   FDA

Daiichi Sankyo Co Ltd., Eli Lilly and Company (JOBS) Win European Approval for Prasugrel

February 23, 2009 | 
1 min read
BOSTON, Feb 23 (Reuters) - Eli Lilly & Co and Japan's Daiichi Sankyo Co said on Monday that they had won European approval for their blood-thinning drug Efient, also known as prasugrel.
FDA Approvals
Eli Lilly and Company Daiichi Sankyo
MORE ON THIS TOPIC
FDA
Leaked MAHA Strategy Emphasizes Vaccine Overhaul, Streamlined Access to Novel Therapies
August 18, 2025
 · 
3 min read
 · 
Heather McKenzie
Composite artwork collage image picture of aged lady hairdo isolated on creative background.
Pain
Tonix Wins Approval For First New Fibromyalgia Drug in Over 15 Years
August 18, 2025
 · 
1 min read
 · 
Tristan Manalac
Novo Nordisk's logo on the facade of its building in Germany
MASH
Novo Wins MASH Approval for Wegovy
August 18, 2025
 · 
2 min read
 · 
Tristan Manalac
The female hand is showing a thumbs-up gesture on a pink background, in an art collage. Positive hand sign. Fashion collage in the style of thumbs up magazine. Contemporary art. Modern design.
Approvals
Precigen Wins First FDA Immunotherapy Nod for Recurrent Respiratory Papillomatosis
August 15, 2025
 · 
1 min read
 · 
Tristan Manalac